Tmunity is a unique biotherapeutics company because of the unrivaled depth of its scientific founders’ and management team’s experience and demonstrated field-specific track record, its mastery of the application of gene-editing and cell engineering tools in human trial settings, the maturity of its clinic-ready development programs, the readiness to scale through its manufacturing processes and facility, and the breadth of its relevant clinical, regulatory, commercial and company-building expertise.
Location: United States, Pennsylvania, East Norriton Township
Employees: 51-200
Total raised: $175M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | LAV | lavfund.co... |
| - | BrightEdge | brightedge... |
| 21.07.2023 | a16z | a16z.com/ |
| - | BrightEdge | acsbrighte... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.11.2019 | Series B | $75M | - |
| 24.01.2018 | Series A | $100M | - |
Mentions in press and media 12
| Date | Title | Description |
| 31.10.2019 | Tmunity Therapeutics Raises $75 Million Series B | PHILADELPHIA--(BUSINESS WIRE)--Tmunity Therapeutics, in pursuit of its vision to save and improve lives by delivering the full potential of next-generation T-cell immunotherapy, closed a $75 million Series B financing. The financing was led... |
| 31.10.2019 | Tmunity Secures $75M in Series B Financing | Tmunity Therapeutics, a Philadelphia, PA-based T-cell immunotherapy company, closed a $75m Series B financing. The round was led by Andreessen Horowitz with participation from a16z’s Cultural Leadership Fund, Westlake Village BioPartners, G... |
| 19.04.2018 | Tmunity Raises Additional $35 Million in Series A Financing | PHILADELPHIA--(BUSINESS WIRE)--Tmunity Therapeutics, Inc., a private, clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today announced an ... |
| 01.02.2018 | Is too much money being invested in oncology? | Oncology is to funding as gravity is to everything else – but is it over the top? Is cancer investment too much, too little or just right? “I’ve been asking this for a number of years,” said Jay Lichter, managing director at Avalon Ventures... |
| 24.01.2018 | Ping An Ventures, Lilly Asia invest in US Tmunity Therapeutics’ $100m funding round | Premium Ping An Ventures, the direct investment arm of China’s Ping An Insurance, and Lilly Asia Ventures took part in the $100-million Series A financing round of Tmunity Therapeutics, the US-based immunotherapy developer that aims to fast... |
| 23.01.2018 | Tmunity Therapeutics Raises $100 Million in Series A | PHILADELPHIA--(BUSINESS WIRE)--Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today announced the ... |
| 23.01.2018 | Tmunity Therapeutics Raises $100M in Series A Financing | Tmunity Therapeutics, Inc., a Philadelphia, PA-based clinical-stage biotherapeutics company, closed a $100m Series A financing. Backers included Ping An Ventures, Parker Institute for Cancer Immunotherapy, Gilead Sciences, Be The Match BioT... |
| 23.01.2018 | Tmunity nabs $100M for next-gen T-cell immunotherapies | Tmunity Therapeutics is looking to bring better and safer T-cell therapies for both solid tumors and blood cancers and has scored a $100 million series A to propel it on its journey. The funding comes from the likes of Ping An Ventures, the... |
| 13.01.2016 | Tmunity Therapeutics Receives $10M Funding | PHILADELPHIA, PA, Tmunity Therapeutics today announced that it is raising $10 Million in equity financing. >> Click here for more funding data on Tmunity Therapeutics >> To export Tmunity Therapeutics funding data to PDF and... |
| 12.01.2016 | Tmunity Therapeutics Raises $10M in Equity Financing | Tmunity Therapeutics, a Philadelphia, PA-based company that is developing novel products that free the immunological potential of T cells to treat a wide range of disease indications, raised $10M in equity financing. Backers included Penn M... |
Show more